Valuation: ResMed, Inc.

Market Cap 28.17B 24.74B 23.01B 21.11B 39.67B 2,712B 40.28B 273B 107B 1,334B 106B 103B 4,611B P/E 2026 *
18.4x
P/E 2027 * 17.2x
Enterprise Value 27.34B 24.01B 22.33B 20.49B 38.5B 2,633B 39.09B 265B 104B 1,294B 103B 100B 4,475B EV / Sales 2026 *
4.84x
EV / Sales 2027 * 4.44x
Free-Float
75.61%
Yield 2026 *
1.25%
Yield 2027 * 1.34%
1 day+1.76%
1 week-1.87%
Current month+0.20%
1 month-0.63%
3 months-11.18%
6 months-22.63%
Current year-18.93%
1 week 190.21
Extreme 190.21
198.73
1 month 190.21
Extreme 190.21
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
7/7/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
8/6/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
1/6/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.76%-1.87%-28.60%-10.49% 28.17B
-0.71%+6.72%+19.63%-0.57% 211B
-0.52%-6.05%-5.58%-25.77% 135B
+1.65%-2.29%-30.93%+4.31% 119B
+1.54%+0.50%-58.34%-15.18% 65.77B
-1.42%-3.62%+9.01%-9.60% 47.58B
+3.03%-0.17%-26.81%-31.58% 44.44B
-0.84%+5.41%+15.14%+8.50% 39.14B
-2.02%+1.54%+25.53%+30.56% 36.79B
-1.41%+3.99%+80.31%+3.20% 29.37B
Average +0.11%-0.11%-0.06%-4.66% 75.63B
Weighted average by Cap. +0.06%+0.15%-2.39%-6.19%

Financials

2026 *2027 *
Net sales 5.65B 4.96B 4.62B 4.24B 7.96B 544B 8.08B 54.81B 21.41B 268B 21.21B 20.76B 925B 5.97B 5.24B 4.87B 4.47B 8.4B 575B 8.53B 57.88B 22.61B 283B 22.4B 21.92B 977B
Net income 1.55B 1.36B 1.26B 1.16B 2.18B 149B 2.21B 15B 5.86B 73.21B 5.8B 5.68B 253B 1.61B 1.42B 1.32B 1.21B 2.27B 155B 2.3B 15.63B 6.11B 76.3B 6.05B 5.92B 264B
Net Debt -827M -726M -675M -620M -1.16B -79.61B -1.18B -8.02B -3.13B -39.14B -3.1B -3.04B -135B -1.65B -1.45B -1.34B -1.23B -2.32B -159B -2.35B -15.97B -6.24B -77.96B -6.18B -6.05B -270B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
24/07/26 USD 195.27 +1.76% 1,005,232
23/07/26 USD 191.89 -0.53% 1,012,467
22/07/26 USD 192.91 -1.48% 971,174
21/07/26 USD 195.80 -1.41% 1,112,740
20/07/26 USD 198.61 -0.19% 1,037,424
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
195.27USD
Average target price
248.60USD
Spread / Average Target
+27.31%

Quarterly revenue - Rate of surprise